Latest Breaking News On - Swiss based roche - Page 1 : comparemela.com

Industry criticizes European Patent Office - examination too superficial

Industry is criticizing the European Patent Office . An initiative of now 21 companies is concerned about the quality of patent examination. We have the impression that the EPO is primarily concerned. | May 26, 2023

Jorg thomaierGabriele mohslerStanding advisory committeeEuropean patent officeIndustry patent quality charterSwiss based rocheEuropean patentBayer ag stock exchangePress releaseRimarily bayn de000bay0017

Lilly overtakes rival to become world s most valuable drugmaker – Inside INdiana Business

Lilly overtakes rival to become world s most valuable drugmaker – Inside INdiana Business
insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.

Eli lillyEvan david siegermanJohn russellMerck coPfizer incEli lilly coIndianapolis businessNew brunswickNew jersey based johnsonDavid siegermanSwiss based rocheNew jersey based merckIllinois based abbvie

Lilly overtakes rival J&J in market cap to become world s most valuable drugmaker – Indianapolis Business Journal

Eli Lilly and Co. shares have soared 57% over the past 52 weeks, buoyed in part by sales of its diabetes drug Mounjaro, which the company is also preparing to seek approval to market for obesity.

Evan david siegermanEli lillyPfizer incMerck coNew brunswickNew jersey based johnsonDavid siegermanSwiss based rocheNew jersey based merckIllinois based abbvie

Spotlight: competition law in the pharmaceutical sector in United Kingdom

This article reviews the application of competition law principles to the pharmaceutical sector in United Kingdom, with particular regard to the merger control regime and anticompetitive behaviour.

United kingdomNorthern irelandAdvanz pharmaPritesh sonpalAdvanz pharma concordiaRobin daviesAmit patelRoche holdings incAuden mckenzie holdingsAlissa healthcare researchConcordia international rx united kingdomFlynn pharmaSpark therapeutics incAbuse of dominanceuk courtNational securityEnglish high court

Avastin wins EU approval for advanced renal cancer

The CHMP issues a positive recommendation for Roche s cancer drug Avastin for use in first-line therapy of advanced renal cell carcinoma

France generalBernard escudierInstitut gustave roussyEuropean committeeMedicinal productsHuman useSwiss based rocheInnovative therapy unitAvastin wins eu approval for advanced renal cancerHe chmp issuesa positive recommendation for roches cancer drug avastin use in first line therapy of advanced renal cell carcinomaNews article